# Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

> **NCT07464132** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Tumor
- Cardiovascular Diseases
- Pulmonary Fibrosis
- Rheumatic Immune Diseases Involving Large Blood Vessels
- Hypertrophic Cardiomyopathy (HCM)
- Other Hypoxic and Fibroblast Activated Diseases

## Interventions

- **DRUG:** Injection of 68Ga-NI-FAPI

## Key facts

- **NCT ID:** NCT07464132
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2027-02-17
- **Final completion:** 2027-06-17
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07464132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07464132, "Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07464132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*